Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Chronic polysystemic candidiasis as a possible contributor to onset of idiopathic Parkinson's disease.

Epp LM, Mravec B.

Bratisl Lek Listy. 2006;107(6-7):227-30. Review.

PMID:
17051898
2.

N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.

Naoi M, Maruyama W, Dostert P, Hashizume Y.

J Neural Transm Suppl. 1997;50:89-105. Review.

PMID:
9120428
3.

[Pathogenesis of idiopathic Parkinson's disease].

Maruyama W.

Nihon Ronen Igakkai Zasshi. 2001 Jul;38(4):494-7. Japanese.

4.

Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.

Antkiewicz-Michaluk L.

Pol J Pharmacol. 2002 Nov-Dec;54(6):567-72. Review.

5.
7.
8.

[Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].

Maruyama W, Naoi M.

Nihon Yakurigaku Zasshi. 2000 Dec;116(6):333-42. Review. Japanese.

PMID:
11188501
9.

Oxidative and nitrative protein modifications in Parkinson's disease.

Danielson SR, Andersen JK.

Free Radic Biol Med. 2008 May 15;44(10):1787-94. doi: 10.1016/j.freeradbiomed.2008.03.005. Epub 2008 Mar 18. Review.

10.

[Salsolinol, an endogenous molecule. Possible implications in alcoholism, Parkinson's disease and pain].

Vernay D, Eschalier A, Durif F, Aumaitre O, Rigal B, Ben Sadoun A, Fialip J, Marty H, Philip E, Bougerolle AM, et al.

Encephale. 1989 Nov-Dec;15(6):511-6. French.

PMID:
2515055
11.

Potential neurotoxic "agents provocateurs" in Parkinson's disease.

Collins MA, Neafsey EJ.

Neurotoxicol Teratol. 2002 Sep-Oct;24(5):571-7. Review.

PMID:
12200188
12.

Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.

Naoi M, Maruyama W, Akao Y, Yi H.

Neurotoxicol Teratol. 2002 Sep-Oct;24(5):579-91. Review.

PMID:
12200189
14.

Cell death in Parkinson's disease.

Maruyama W, Naoi M.

J Neurol. 2002 Sep;249 Suppl 2:II6-10.

PMID:
12375057
15.

An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.

Maruyama W, Naoi M, Kasamatsu T, Hashizume Y, Takahashi T, Kohda K, Dostert P.

J Neurochem. 1997 Jul;69(1):322-9.

16.

A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol.

Naoi M, Maruyama W, Dostert P, Kohda K, Kaiya T.

Neurosci Lett. 1996 Jul 19;212(3):183-6.

PMID:
8843103
17.

N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.

Naoi M, Maruyama W.

Adv Neurol. 1999;80:259-64. Review. No abstract available.

PMID:
10410730
18.

Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.

Naoi M, Maruyama W, Kasamatsu T, Dostert P.

J Neural Transm Suppl. 1998;52:125-38.

PMID:
9564615
19.

Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.

Zheng X, Chen X, Guo M, Ali S, Huang Y, Sun F, Liu K, Chen Z, Deng Y, Zhong R.

Neurosci Lett. 2018 Apr 23;673:39-43. doi: 10.1016/j.neulet.2018.02.024. Epub 2018 Feb 15.

PMID:
29454627
20.

Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.

Wąsik A, Romańska I, Michaluk J, Antkiewicz-Michaluk L.

Neurotox Res. 2015 May;27(4):399-410. doi: 10.1007/s12640-015-9523-2. Epub 2015 Feb 25.

Supplemental Content

Support Center